Left Atrial Strain and Cryptogenic Stroke

Recruiting Observational Study
Ischemic Stroke, Cryptogenic Ischemic Stroke, Embolic Hemorrhagic Stroke Embolic Stroke of Undetermined Source Recurrent Ischemic Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
900 (estimated)
Sponsor
University of Pittsburgh · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cryptogenic stroke is a type of stroke in which the cause of the blood clot cannot be identified, leaving many patients without a clear treatment plan and at high risk for another stroke. Current medical guidelines recommend blood-thinning medication (anticoagulation) only when atrial fibrillation (AF) -an irregular heart rhythm- can be documented. However, AF may occur silently and remain undetec…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult patients (age \> 18 years and \< 80 years) who had a complete transthoracic echocardiography (TTE) exam at the University of Pittsburgh Medical Center (UPMC) Presbyterian Echocardiography Lab with a referral diagnosis of suspected stroke. 2- Patients with an establish…
Contacts

Leyla E Sade, MD

412-215-3464

sadele2@upmc.edu

CONTACT

Benay Ozbay, MD

412-450-2774

ozbayb@upmc.edu

CONTACT